Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid

Status

Completed

Phases

Phase 1Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01179633

Enrollment

Registered

2010-08-11

Start date

2010-03-31

Completion date

2010-06-30

Last updated

2010-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris

Brief summary

The purpose of this study was to demonstrate the effect of short treatment with active OPLON patches on Acne.

Detailed description

Patients with Acne Vulgaris were treated overnight with active patches. Effect is observed at the end of the treatment and 24 hours later.

Interventions

DEVICEOPLON active patch

DEVICESham patch

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Acne Vulgaris * Over 18 years * Signing informed consent

Exclusion criteria

* Active treatment of acne * Change in hormonal therapy * Antibiotic treatment in a week prior to the experiment * Sensitive skin * Pregnancy

Design outcomes

Primary

Measure	Time frame	Description
Severity Score of lesion	•Severity Score of lesion [Time Frame: 24 hours following patch removal]	Lesions were ranked by investigator according to severity whereas: 0-clear, 1-mild, 2-moderate, 3-sever

Secondary

Measure	Time frame	Description
Severity Score of lesion	•Severity Score of lesion [Time Frame: 12 hours with the patch]	0-clear, 1-mild, 2-moderate, 3-sever

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026